期刊文献+

Training stem cells for treatment of malignant brain tumors

Training stem cells for treatment of malignant brain tumors
下载PDF
导出
摘要 The treatment of malignant brain tumors remains a challenge. Stem cell technology has been applied in the treatment of brain tumors largely because of the ability of some stem cells to infiltrate into regions within the brain where tumor cells migrate as shown in preclinical studies. However, not all of these efforts can translate in the effective treatment that improves the quality of life for pa-tients. Here, we perform a literature review to identify the problems in the field. Given the lack of efficacy of most stem cell-based agents used in the treatment of malignant brain tumors, we found that stem cell distribution(i.e., only a fraction of stem cells applied capable of targeting tumors) are among the limiting factors. We provide guidelines for potential improvements in stem cell distribution. Specifically, we use an engineered tissue graft platform that replicates the in vivo microenvironment, and provide our data to validate that this culture platform is viable for producing stem cells that have better stem cell distribution than with the Petri dish culture system. The treatment of malignant brain tumors remains a challenge. Stem cell technology has been applied in the treatment of brain tumors largely because of the ability of some stem cells to infiltrate into regions within the brain where tumor cells migrate as shown in preclinical studies. However, not all of these efforts can translate in the effective treatment that improves the quality of life for pa-tients. Here, we perform a literature review to identify the problems in the field. Given the lack of efficacy of most stem cell-based agents used in the treatment of malignant brain tumors, we found that stem cell distribution(i.e., only a fraction of stem cells applied capable of targeting tumors) are among the limiting factors. We provide guidelines for potential improvements in stem cell distribution. Specifically, we use an engineered tissue graft platform that replicates the in vivo microenvironment, and provide our data to validate that this culture platform is viable for producing stem cells that have better stem cell distribution than with the Petri dish culture system.
出处 《World Journal of Stem Cells》 SCIE CAS 2014年第4期432-440,共9页 世界干细胞杂志(英文版)(电子版)
基金 Supported by The CHOC Children’s Foundation,CHOC Neuroscience Institute,CHOC Research Institute,The Austin Ford Tribute and Keck Foundation by The United States National Institutes of Health,1R01CA164509-01 The United States National Science Foundation,CHE-1213161
关键词 Stem cells MALIGNANT brain TUMORS Engineered TISSUE GRAFT ORGANOTYPIC SLICE model Stem cells Malignant brain tumors Engineered tissue graft Organotypic slice model
  • 相关文献

参考文献18

  • 1Rachael Mooney,Yiming Weng,Revathiswari Tirughana-Sambandan,Valerie Valenzuela,Soraya Aramburo,Elizabeth Garcia,Zhongqi Li,Margarita Gutova,Alexander J Annala,Jacob M Berlin,Karen S Aboody.Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution[J]. Future Oncology . 2014 (3)
  • 2D. L. Whiting,G. K. Simpson,E.-S. Koh,K. M. Wright,T. Simpson,R. Firth.A multi-tiered intervention to address behavioural and cognitive changes after diagnosis of primary brain tumour: A feasibility study[J]. Brain Injury . 2012 (7-8)
  • 3Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma[J]. Cancer Cell . 2012 (4)
  • 4Shengwen Calvin Li,Julyana Acevedo,Lang Wang,Hong Jiang,Jane Luo,Richard G. Pestell,William G. Loudon,Anthony C. Chang.Mechanisms for Progenitor Cell-Mediated Repair for Ischemic Heart Injury[J]. Current Stem Cell ResearchandTherapy . 2012 (1)
  • 5Richard T. Frank,Karen S. Aboody,Joseph Najbauer.Strategies for enhancing antibody delivery to the brain[J]. BBA - Reviews on Cancer . 2011 (2)
  • 6Roel G.W. Verhaak,Katherine A. Hoadley,Elizabeth Purdom,Victoria Wang,Yuan Qi,Matthew D. Wilkerson,C. Ryan Miller,Li Ding,Todd Golub,Jill P. Mesirov,Gabriele Alexe,Michael Lawrence,Michael O’Kelly,Pablo Tamayo,Barbara A. Weir,Stacey Gabriel,Wendy Winckler,Supriya Gupta,Lakshmi Jakkula,Heidi S. Feiler,J. Graeme Hodgson,C. David James,Jann N. Sarkaria,Cameron Brennan,Ari Kahn,Paul T. Spellman,Richard K. Wilson,Terence P. Speed,Joe W. Gray,Matthew Meyerson,Gad Getz,Charles M. Perou,D. Neil Hayes.Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH1 , EGFR , and NF1[J]. Cancer Cell . 2010 (1)
  • 7Shengwen Calvin Li,Lisa May Ling Tachiki,Jane Luo,Brent A. Dethlefs,Zhongping Chen,William G. Loudon.A Biological Global Positioning System: Considerations for Tracking Stem Cell Behaviors in the Whole Body[J]. Stem Cell Reviews and Reports . 2010 (2)
  • 8Shengwen Calvin Li,Lang Wang,Hong Jiang,Julyana Acevedo,Anthony Christopher Chang,William Gunter Loudon.Stem cell engineering for treatment of heart diseases: Potentials and challenges[J]. Cell Biology International . 2008 (3)
  • 9Jennifer Hipp,Anthony Atala.Sources of Stem Cells for Regenerative Medicine[J]. Stem Cell Reviews . 2008 (1)
  • 10Sarah Bradley,Paula R. Sherwood,Heidi S. Donovan,Rebekah Hamilton,Margaret Rosenzweig,Allison Hricik,Alyssa Newberry,Catherine Bender.I could lose everything: understanding the cost of a brain tumor[J]. Journal of Neuro - Oncology . 2007 (3)

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部